Intellia Therapeutics Inc.

In News

NTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late - Stocktwits

Stocktwits - Sep 19, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics

Intellia Therapeutics - Sep 08, 2026

Can Intellia's Pipeline Progress Create Long-Term Value Amid Rivalry? - Eastern Progress

Eastern Progress - Sep 18, 2026

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A Look At Its 95.76% Potential Upside - DirectorsTalk Interviews

DirectorsTalk Interviews - Sep 18, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Sep 04, 2026

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics

Intellia Therapeutics - Aug 06, 2026

Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances - Yahoo Finance

Yahoo Finance - Sep 19, 2026

Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire

GlobeNewswire - Sep 04, 2026

Intellia Therapeutics Q2 Earnings Call Highlights - Yahoo Finance

Yahoo Finance - Aug 06, 2026

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema - Intellia Therapeutics

Intellia Therapeutics - Jun 13, 2026

Is Intellia Therapeutics, Inc. (NTLA) A Good Stock To Buy Now? - Yahoo Finance

Yahoo Finance - Jul 03, 2026

Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics

Intellia Therapeutics - Jul 30, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment